Ningxia Zhongke Biotechnology Co (SHSE:600165) EPS (Basic): ¥-0.21 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
53 GF Score
Price ¥2.43
GF Value ¥2.77
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co EPS (Basic)?

Ningxia Zhongke Biotechnology Co SHSE:600165 +9.95% 53 EPS (Basic) is ¥-0.21 as of Mar. 2026. GuruFocus rates SHSE:600165 with a GF Score™ of 53/100 and a GF Value™ of ¥2.77 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Ningxia Zhongke Biotechnology Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.21.

Ningxia Zhongke Biotechnology Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.21.

Ningxia Zhongke Biotechnology Co's EPS without NRI for the three months ended in Mar. 2026 was ¥-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.15.

During the past 3 years, the average EPS without NRI Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ningxia Zhongke Biotechnology Co's highest 3-Year average EPS without NRI Growth Rate was 100.80% per year. The lowest was -147.50% per year. And the median was -8.35% per year.

Ningxia Zhongke Biotechnology Co  (SHSE:600165) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ningxia Zhongke Biotechnology Co EPS (Basic) Related Terms

Ningxia Zhongke Biotechnology Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Ningxia Zhongke Biotechnology Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningxia Zhongke Biotechnology Co EPS (Basic) Chart

Ningxia Zhongke Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.31 -0.68 -0.79 -0.06

Ningxia Zhongke Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.16 -0.12 0.10 -0.04
SHSE:600165
53GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningxia Zhongke Biotechnology Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ningxia Zhongke Biotechnology Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-90.377-0)/1613.873
=-0.06

Ningxia Zhongke Biotechnology Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-64.316-0)/1607.888
=-0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥-0.21 mean?
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a EPS (Basic) of ¥-0.21 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ningxia Zhongke Biotechnology Co and its competitors.
Is Ningxia Zhongke Biotechnology Co's EPS (Basic) too high?
Ningxia Zhongke Biotechnology Co's current EPS (Basic) is ¥-0.21. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's EPS (Basic) compare to LIN and SHW?
Ningxia Zhongke Biotechnology Co's EPS (Basic) of ¥-0.21 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Chemicals company?
A good EPS (Basic) depends on the Chemicals industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. Ningxia Zhongke Biotechnology Co's current EPS (Basic) is ¥-0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥2.77, compared to a current price of ¥2.43 — trading 12.3% below its estimated fair value. The current EPS (Basic) is ¥-0.21. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current EPS (Basic) is ¥-0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be undervalued. The current stock price of ¥2.43 is trading 12.3% below its estimated GF Value™ of ¥2.77. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600165:

  • EPS (Basic): ¥-0.21
  • GF Value™: ¥2.77 vs. price of ¥2.43 (12.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
53GF Score

Get the complete analysis for SHSE:600165

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.43
Price
¥2.77
GF Value